Unknown

Dataset Information

0

Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach.


ABSTRACT:

Objective

To construct and internally validate prediction models to estimate the risk of long-term end-organ complications and mortality in patients with type 2 diabetes and obesity that can be used to inform treatment decisions for patients and practitioners who are considering metabolic surgery.

Research design and methods

A total of 2,287 patients with type 2 diabetes who underwent metabolic surgery between 1998 and 2017 in the Cleveland Clinic Health System were propensity-matched 1:5 to 11,435 nonsurgical patients with BMI ≥30 kg/m2 and type 2 diabetes who received usual care with follow-up through December 2018. Multivariable time-to-event regression and random forest machine learning models were built and internally validated using fivefold cross-validation to predict the 10-year risk for four outcomes of interest. The prediction models were programmed to construct user-friendly web-based and smartphone applications of Individualized Diabetes Complications (IDC) Risk Scores for clinical use.

Results

The prediction tools demonstrated the following discrimination ability based on the area under the receiver operating characteristic curve (1 = perfect discrimination and 0.5 = chance) at 10 years in the surgical and nonsurgical groups, respectively: all-cause mortality (0.79 and 0.81), coronary artery events (0.66 and 0.67), heart failure (0.73 and 0.75), and nephropathy (0.73 and 0.76). When a patient's data are entered into the IDC application, it estimates the individualized 10-year morbidity and mortality risks with and without undergoing metabolic surgery.

Conclusions

The IDC Risk Scores can provide personalized evidence-based risk information for patients with type 2 diabetes and obesity about future cardiovascular outcomes and mortality with and without metabolic surgery based on their current status of obesity, diabetes, and related cardiometabolic conditions.

SUBMITTER: Aminian A 

PROVIDER: S-EPMC7646205 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8401745 | biostudies-literature
| S-EPMC8390484 | biostudies-literature
| S-EPMC8365303 | biostudies-literature
| S-EPMC7890310 | biostudies-literature
| S-EPMC6325823 | biostudies-other
| S-EPMC6405084 | biostudies-literature
| S-EPMC6060003 | biostudies-literature
| S-EPMC8716451 | biostudies-literature
| S-EPMC8051758 | biostudies-literature
| S-EPMC7881135 | biostudies-literature